Agrin (AGRN) has been described as a multifunctional heparan sulfate proteoglycan, which can regulate angiogenesis and has a board-ranging impact on the tumor microenvironment (TME) in HCC and papillary thyroid carcinoma (PTC) [25, 26]. The gene discussed is CD44; the disease is differentiated thyroid carcinoma.